DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
EVATANEPAG
2
Small molecule
Investigational
Unknown
Unknown
Tibial Fractures
Prostanoid EP2 receptor agonist
EVATANEPAG
×
Maximum Phase:
2
First Approval:
None
UNII:
L266R6E31E
Molecule Type:
Small molecule
Molecular Formula:
C25H28N2O5S
Molecular Weight:
468.58
AlogP:
4.23
PSA:
96.8
HBD:
1.0
HBA:
#RotB:
9.0
Source:
MITOGLITAZONE
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Diabetes Mellitus, Type 2
Unknown
MITOGLITAZONE
×
Maximum Phase:
2
First Approval:
None
UNII:
29I7RP18RG
Molecule Type:
Small molecule
Molecular Formula:
C19H18N2O4S
Molecular Weight:
370.43
AlogP:
2.8
PSA:
85.36
HBD:
1.0
HBA:
#RotB:
7.0
Source:
BGC-20-1531 FREE BASE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BGC-20-1531 FREE BASE
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C26H24N2O6S
Molecular Weight:
492.55
AlogP:
4.66
PSA:
107.73
HBD:
1.0
HBA:
#RotB:
8.0
Source:
MARDEPODECT
2
Small molecule
Investigational
Unknown
Unknown
Huntington Disease; Schizophrenia
Unknown
MARDEPODECT
×
Maximum Phase:
2
First Approval:
None
UNII:
R9Y8EY0G42
Molecule Type:
Small molecule
Molecular Formula:
C25H20N4O
Molecular Weight:
392.46
AlogP:
5.28
PSA:
52.83
HBD:
0.0
HBA:
#RotB:
5.0
Source:
DEFERITAZOLE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DEFERITAZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
4D8DC53Y1L
Molecule Type:
Small molecule
Molecular Formula:
C18H25NO7S
Molecular Weight:
399.47
AlogP:
1.79
PSA:
106.81
HBD:
2.0
HBA:
#RotB:
12.0
Source:
RG-547
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Cyclin-dependent kinase 1 inhibitor
RG-547
×
Maximum Phase:
2
First Approval:
None
UNII:
T61871RKRI
Molecule Type:
Small molecule
Molecular Formula:
C18H21F2N5O4S
Molecular Weight:
441.46
AlogP:
1.41
PSA:
127.51
HBD:
2.0
HBA:
#RotB:
6.0
Source:
DECERNOTINIB
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
Tyrosine-protein kinase JAK3 inhibitor
DECERNOTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
MZK2GP0RHK
Molecule Type:
Small molecule
Molecular Formula:
C18H19F3N6O
Molecular Weight:
392.39
AlogP:
3.28
PSA:
95.59
HBD:
3.0
HBA:
#RotB:
6.0
Source:
CE-326597
2
Small molecule
Investigational
Unknown
Unknown
Obesity
Cholecystokinin A receptor agonist
CE-326597
×
Maximum Phase:
2
First Approval:
None
UNII:
1FGZ6L9SF2
Molecule Type:
Small molecule
Molecular Formula:
C37H34N6O2
Molecular Weight:
594.72
AlogP:
6.53
PSA:
87.12
HBD:
1.0
HBA:
#RotB:
8.0
Source:
BISANTRENE
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Alpha-ketoglutarate-dependent dioxygenase FTO inhibitor
BISANTRENE
×
Maximum Phase:
2
First Approval:
None
UNII:
39C34M111K
Molecule Type:
Small molecule
Molecular Formula:
C22H22N8
Molecular Weight:
398.47
AlogP:
1.76
PSA:
97.56
HBD:
4.0
HBA:
#RotB:
4.0
Source:
PARTHENOLIDE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PARTHENOLIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
2RDB26I5ZB
Molecule Type:
Small molecule
Molecular Formula:
C15H20O3
Molecular Weight:
248.32
AlogP:
2.76
PSA:
38.83
HBD:
0.0
HBA:
#RotB:
0.0
Source:
BPN-14770
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BPN-14770
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ELSUBRUTINIB
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Lupus Erythematosus, Systemic
Tyrosine-protein kinase BTK inhibitor
ELSUBRUTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
1487U1Q3IQ
Molecule Type:
Small molecule
Molecular Formula:
C17H19N3O2
Molecular Weight:
297.36
AlogP:
2.16
PSA:
79.19
HBD:
2.0
HBA:
#RotB:
3.0
Source:
FOSBRETABULIN
2
Small molecule
Investigational
Unknown
Unknown
Ovarian Neoplasms; Neoplasms; Neuroendocrine Tumors; Thyroid Neoplasms
Unknown
FOSBRETABULIN
×
Maximum Phase:
2
First Approval:
None
UNII:
I5590ES2QZ
Molecule Type:
Small molecule
Molecular Formula:
C18H21O8P
Molecular Weight:
396.33
AlogP:
3.36
PSA:
103.68
HBD:
2.0
HBA:
#RotB:
8.0
Source:
JNJ-54861911
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
JNJ-54861911
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACOZIBOROLE
2
Small molecule
Investigational
Unknown
Unknown
Trypanosomiasis, African
Cleavage and polyadenylation specificity factor subunit inhibitor
ACOZIBOROLE
×
Maximum Phase:
2
First Approval:
None
UNII:
2IOR2OO3GW
Molecule Type:
Small molecule
Molecular Formula:
C17H14BF4NO3
Molecular Weight:
367.11
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
7-METHYLXANTHINE
2
Small molecule
Investigational
Unknown
Unknown
Myopia
Unknown
7-METHYLXANTHINE
×
Maximum Phase:
2
First Approval:
None
UNII:
E9M81NJM6G
Molecule Type:
Small molecule
Molecular Formula:
C6H6N4O2
Molecular Weight:
166.14
AlogP:
-0.23
PSA:
84.06
HBD:
2.0
HBA:
#RotB:
0.0
Source:
DELPAZOLID
2
Small molecule
Investigational
Unknown
Unknown
Tuberculosis, Pulmonary
Bacterial 70S ribosome inhibitor
DELPAZOLID
×
Maximum Phase:
2
First Approval:
None
UNII:
43EP6XV33E
Molecule Type:
Small molecule
Molecular Formula:
C14H17FN4O3
Molecular Weight:
308.31
AlogP:
0.84
PSA:
68.61
HBD:
1.0
HBA:
#RotB:
3.0
Source:
IBIPINABANT
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Obesity
Cannabinoid CB1 receptor antagonist
IBIPINABANT
×
Maximum Phase:
2
First Approval:
None
UNII:
O5CSC6WH1T
Molecule Type:
Small molecule
Molecular Formula:
C23H20Cl2N4O2S
Molecular Weight:
487.41
AlogP:
4.76
PSA:
74.13
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ONO-2333MS
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major
Corticotropin releasing factor receptor 1 antagonist
ONO-2333MS
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MOXAVERINE
2
Small molecule
Investigational
Unknown
Unknown
Digestive System Diseases; Ischemia
Unknown
MOXAVERINE
×
Maximum Phase:
2
First Approval:
None
UNII:
P3P08Y1XJ4
Molecule Type:
Small molecule
Molecular Formula:
C20H21NO2
Molecular Weight:
307.39
AlogP:
4.41
PSA:
31.35
HBD:
0.0
HBA:
#RotB:
5.0
Source:
YM-543
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Sodium/glucose cotransporter 2 inhibitor
YM-543
×
Maximum Phase:
2
First Approval:
None
UNII:
KA83KI0EO9
Molecule Type:
Small molecule
Molecular Formula:
C28H37NO7
Molecular Weight:
499.6
AlogP:
1.6
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
4.0
Source:
AZD0328
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Schizophrenia
Neuronal acetylcholine receptor protein alpha-7 subunit agonist
AZD0328
×
Maximum Phase:
2
First Approval:
None
UNII:
2B218X5QIY
Molecule Type:
Small molecule
Molecular Formula:
C13H16N2O
Molecular Weight:
216.28
AlogP:
1.48
PSA:
25.36
HBD:
0.0
HBA:
#RotB:
0.0
Source:
AVADOMIDE
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Renal Insufficiency; Melanoma
Unknown
AVADOMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
28DZS29F59
Molecule Type:
Small molecule
Molecular Formula:
C14H14N4O3
Molecular Weight:
286.29
AlogP:
0.26
PSA:
107.08
HBD:
2.0
HBA:
#RotB:
1.0
Source:
EMIVIRINE
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
EMIVIRINE
×
Maximum Phase:
2
First Approval:
None
UNII:
X87G8IX72O
Molecule Type:
Small molecule
Molecular Formula:
C17H22N2O3
Molecular Weight:
302.37
AlogP:
2.24
PSA:
64.09
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CK-2127107
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CK-2127107
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INDISULAM
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Stomach Neoplasms; Breast Neoplasms; Carcinoma, Renal Cell; Colorectal Neoplasms; Leukemia; Melanoma
Unknown
INDISULAM
×
Maximum Phase:
2
First Approval:
None
UNII:
WJ98J3NM90
Molecule Type:
Small molecule
Molecular Formula:
C14H12ClN3O4S2
Molecular Weight:
385.85
AlogP:
2.27
PSA:
122.12
HBD:
3.0
HBA:
#RotB:
4.0
Source:
METHYLINOSITOL
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
METHYLINOSITOL
×
Maximum Phase:
2
First Approval:
None
UNII:
TF9HZN9T0M
Molecule Type:
Small molecule
Molecular Formula:
C7H14O6
Molecular Weight:
194.18
AlogP:
-3.18
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
1.0
Source:
LUTEOLIN
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LUTEOLIN
×
Maximum Phase:
2
First Approval:
None
UNII:
KUX1ZNC9J2
Molecule Type:
Small molecule
Molecular Formula:
C15H10O6
Molecular Weight:
286.24
AlogP:
2.28
PSA:
111.13
HBD:
4.0
HBA:
#RotB:
1.0
Source:
GOSSYPOL ACETIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Central Nervous System Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Multiple Myeloma; Adrenal Cortex Neoplasms; Gliosarcoma; Small Cell Lung Carcinoma
Unknown
GOSSYPOL ACETIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
S7RL72610R
Molecule Type:
Small molecule
Molecular Formula:
C42H42O14
Molecular Weight:
770.78
AlogP:
7.7
PSA:
191.94
HBD:
0.0
HBA:
#RotB:
11.0
Source:
ORTATAXEL
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Renal Cell; Glioblastoma; Kidney Neoplasms; Lung Neoplasms; Lymphoma
Unknown
ORTATAXEL
×
Maximum Phase:
2
First Approval:
None
UNII:
8H61Y4E29N
Molecule Type:
Small molecule
Molecular Formula:
C44H57NO17
Molecular Weight:
871.93
AlogP:
3.66
PSA:
245.82
HBD:
3.0
HBA:
#RotB:
10.0
Source:
VENGLUSTAT MALATE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VENGLUSTAT MALATE
×
Maximum Phase:
2
First Approval:
None
UNII:
94855LQZ8D
Molecule Type:
Small molecule
Molecular Formula:
C24H30FN3O7S
Molecular Weight:
523.58
AlogP:
4.0
PSA:
54.46
HBD:
1.0
HBA:
#RotB:
4.0
Source:
RELMAPIRAZIN
2
Small molecule
Investigational
Unknown
Unknown
Acute Kidney Injury
Unknown
RELMAPIRAZIN
×
Maximum Phase:
2
First Approval:
None
UNII:
Q3UQB8PQ6H
Molecule Type:
Small molecule
Molecular Formula:
C12H16N6O8
Molecular Weight:
372.29
AlogP:
-4.01
PSA:
251.08
HBD:
8.0
HBA:
#RotB:
8.0
Source:
GSK-2269557
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Pulmonary Disease, Chronic Obstructive
PI3-kinase p110-delta subunit inhibitor
GSK-2269557
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OLCEGEPANT
2
Small molecule
Investigational
Unknown
Unknown
Migraine Disorders
Calcitonin gene-related peptide type 1 receptor antagonist
OLCEGEPANT
×
Maximum Phase:
2
First Approval:
None
UNII:
WOA5J8TX6M
Molecule Type:
Small molecule
Molecular Formula:
C38H47Br2N9O5
Molecular Weight:
869.66
AlogP:
4.41
PSA:
176.47
HBD:
5.0
HBA:
#RotB:
12.0
Source:
BALICATIB
2
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis; Osteoporosis
Cathepsin K inhibitor
BALICATIB
×
Maximum Phase:
2
First Approval:
None
UNII:
E00MVC7O57
Molecule Type:
Small molecule
Molecular Formula:
C23H33N5O2
Molecular Weight:
411.55
AlogP:
2.29
PSA:
88.47
HBD:
2.0
HBA:
#RotB:
7.0
Source:
1
2
…
102
103
104
105
106
107
108
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA